For NAD+ storage and stability, keep the lyophilized powder sealed, dry, dark and frozen. Its main weak point is alkaline pH, which matters more than temperature. The bond between nicotinamide and ribose breaks quickly above pH 7. Let a cold vial reach room temperature before opening it, so water does not condense on the powder.
- NAD+ degrades fastest by base-catalysed cleavage of the nicotinamide-ribose bond, so pH controls its fate more than freezer temperature does.
- NAD+ and NADH have opposite stability profiles: the oxidised form tolerates acid and fails in base, the reduced form does the reverse.
- Free-acid NAD+ is hygroscopic, so water content and assay from the certificate are needed to convert a nominal vial mass into a real NAD+ content.
- Purity by chromatographic area and content by mass are separate numbers, and a competent certificate reports both.
What this guide covers
Think of NAD+ powder like instant coffee in a jar. Kept dry and sealed it lasts a long time. Let damp air in and it clumps.
This guide covers why peptide handling rules do not carry over to NAD+, the pH asymmetry that drives its breakdown, conditions for the sealed powder, the condensation problem, how degradation shows up on an assay, and what the lab record should say.
- Alkaline pH — cleaves the nicotinamide-ribose bond, the fastest route
- Water — moves the solid into the same regime as a solution
- Temperature — a rate modifier on every route
- Reducing agents — quiet conversion to NADH
- Microbial glycohydrolases — enzymatic cleavage
Why don't peptide handling rules transfer to NAD+?
β-Nicotinamide adenine dinucleotide, oxidized form, is a small molecule by the standards of this catalog: an adenine nucleotide joined through a pyrophosphate bridge to a nicotinamide riboside. CAS 53-84-9, formula C21H27N7O14P2, formula weight 663.43 for the free acid. Material is supplied either as the free acid, usually as a hydrate, or as a mono- or disodium salt. Which one you have changes the formula weight, changes how acidic the material is, and therefore changes its stability window. The certificate should say. If it does not, that is the first question for the supplier.
Peptide storage guidance circulates widely enough that it gets applied to anything sold as a lyophilized white powder in a vial. Most of it is beside the point here. NAD+ has no peptide backbone to hydrolyze, no methionine to oxidize, and it does not aggregate at an air-water interface the way a lipidated peptide does, so agitation is a minor concern. What it has instead is a glycosidic bond to the nicotinamide ring that base attacks readily, a pyrophosphate linkage that acid and heat attack slowly, and a redox partner in NADH whose stability profile runs in the opposite direction. Handling NAD+ well means controlling water, then pH, then temperature, in about that order of consequence.
One practical consequence of the free-acid form: it is hygroscopic, and the water it picks up counts in the vial mass. A certificate that reports water content by Karl Fischer or loss on drying, alongside a purity assay, lets you correct nominal mass to actual NAD+ content. Without those two numbers, a stated 10 mg is a fill target rather than a quantity of compound, and every downstream figure inherits the difference.
Why does pH matter more than temperature?
The oxidized and reduced pyridine nucleotides are mirror images in their chemical vulnerability. NAD+ tolerates acid and degrades quickly in base. NADH tolerates base and degrades quickly in acid. Lowry, Passonneau and Rock quantified this in the early 1960s, and the finding has held up because it follows directly from the chemistry: hydroxide adds at the C4 position of the oxidized nicotinamide ring, and the resulting adducts go on to fluorescent products, while the reduced ring is the one that is acid-labile.
In chemical terms, pH 7.4 already sits on the losing side for NAD+, and anything above pH 8 is actively hostile.
| Route | Products | What drives it | Practical control |
|---|---|---|---|
| Glycosidic cleavage at the nicotinamide-ribose bond | Nicotinamide plus ADP-ribose | Alkaline pH, heat, water activity | Keep powder dry and away from alkaline conditions |
| Base adduct formation at ring C4 | Fluorescent nicotinamide adducts | Hydroxide concentration | Avoid alkaline conditions |
| Pyrophosphate hydrolysis | NMN plus AMP | Strong acid, heat, prolonged contact with water | Cold, dry storage |
| Reduction to NADH | NADH, then acid-labile in turn | Reducing agents such as thiols or dithionite | Keep away from reducing agents |
| Enzymatic cleavage | Nicotinamide, ADP-ribose, free phosphate | Microbial NAD glycohydrolases and phosphatases | Clean technique; cold storage |
| Moisture uptake by the cake | No new species, but mass and rate errors | Ambient humidity, cold vial surfaces | Equilibrate before opening; reseal over desiccant |
Temperature is absent from the top of that list for the same reason it was absent in the peptide case. Cold slows all of these routes and is worth having. It does not address pH.
How should sealed NAD+ powder be stored?
Dry, sealed and cold is a slow regime for this compound. Suppliers commonly specify minus 20 °C, desiccated, protected from light, and that specification is reasonable. Ambient shipping of the dry solid over a few days is a normal excursion and the least of the worries.
| State | Temperature | Light | Relative horizon | Why |
|---|---|---|---|---|
| Sealed powder, unopened | Minus 20 °C or below, over desiccant | Dark | Longest | Water excluded, all routes slowed |
| Sealed powder, in use | 2 to 8 °C, over desiccant | Dark | Shorter | Acceptable where the vial is consumed within a defined window |
| Powder in transit | Ambient | Dark, insulated | Days | The dry solid tolerates short excursions |
Those horizons are relative on purpose. A shelf life expressed in months belongs to a lot that has had a stability study run on it, in that container, under those conditions, on the design principles ICH Q1A(R2) sets out. Where no such study exists, the honest statement is that the window is unestablished, and the lot certificate is the only document with any standing to carry a date. Our own position on what a certificate should contain is set out in the quality standard.
What does condensation do to the cake?
Take a vial out of a minus 20 freezer into a room at 22 °C and 60 percent relative humidity, and the glass sits far below the dew point. Break the seal at that moment and water condenses inside the vial, onto a lyophilized solid that is happy to take it up. Nothing about the appearance changes in any way a person can read. The vial then goes back to the freezer with water in it, and the next operator inherits a slightly different material than the label describes.
The control is dull and works: let the sealed vial reach room temperature before breaking the seal, every time. Twenty to thirty minutes on the bench suits a small vial. Work quickly once it is open, reseal over fresh desiccant, and log the excursion if the protocol tracks them.
There is a second reason to care about moisture here beyond degradation rate. A cake that has taken up water weighs more than the NAD+ it contains, so any weighing done on partially hydrated material overstates the NAD+ present. If a vial is being subdivided by weight, that bias goes straight into the numbers and nothing downstream will reveal it.
How does degradation show up analytically?
NAD+ is straightforward to assay. Reversed-phase HPLC on a C18 column with an aqueous phosphate or ammonium acetate mobile phase, ion-pairing if retention is poor, detection at 260 nm, resolves the parent from its main degradants comfortably. System suitability expectations for that kind of method are the ordinary ones set out in USP General Chapter <621>. Where identity confirmation is required, LC-MS in negative mode gives the deprotonated parent near m/z 662, and the diagnostic fragment is loss of the nicotinamide ring at 122 Da.
| Observation | Likely cause | Where it shows |
|---|---|---|
| Early-eluting peak with strong 260 nm response | ADP-ribose from glycosidic cleavage | RP-HPLC purity trace |
| Small polar peak, weak 260 nm response | Free nicotinamide | RP-HPLC; positive-mode LC-MS near m/z 123 |
| Absorbance at 340 nm above baseline | NADH present, whether from reduction or from the original material | UV scan of the stock |
| Fluorescence on alkaline treatment | Base adducts of the nicotinamide ring | Fluorimetric check, historically the classic assay |
| Yellowing of the solid or solution | Advanced or heat-driven decomposition | Visual inspection |
| Total purity intact, assay low | Water content or fill mass, not degradation | Certificate cross-check |
The last row is the one people miss. A purity figure of 99 percent by area says nothing about how much material is in the vial. Purity and content are separate numbers and a competent certificate reports both.
What to check on the certificate
Before a lot goes into storage, check its certificate for these lines. A certificate reporting only one of purity and content leaves your content figure guessing.
- Purity by HPLC with the chromatogram attached.
- Identity by mass spectrometry or a comparable orthogonal method.
- Water content by Karl Fischer or loss on drying.
- The salt form and formula weight used.
- Residual solvents where relevant.
- A lot number that matches the vial.
What should the record say?
Storage discipline that is not written down is not reproducible. For a sealed vial the minimum record is the lot identifier, the date received, the storage location and temperature, and each opening with its date and the initials of whoever opened it.
The reason is diagnostic rather than administrative. When a result comes back low, the first question is whether the material was what the method assumed. A record that runs from the result back through the vial to the lot to the certificate answers that in a minute. A record that stops short means repeating the work.
How to handle a sealed NAD+ vial: step by step
The handling that protects a sealed vial is short and repetitive:
- Store it sealed, cold, dry and dark. Minus 20 °C or below over desiccant for unopened powder.
- Let the sealed vial reach room temperature before breaking the seal. Twenty to thirty minutes on the bench suits a small vial.
- Work quickly once it is open. Then reseal over fresh desiccant and log the excursion if the protocol tracks them.
- Log every opening. Record the date, the lot identifier and the initials of whoever opened the vial.
What is the regulatory position?
NAD+ is an endogenous coenzyme and a widely sold laboratory reagent. There is no FDA-approved injectable NAD+ drug product in the United States, and material supplied for laboratory work is not manufactured under the sterility, endotoxin and lot-release controls that a licensed parenteral would require. NAD+ has been among the bulk drug substances nominated for use in pharmacy compounding under section 503A; the current category assignment and the agency reasoning behind it should be read from FDA's published list rather than from secondary summaries, which lag.
Related precursors have their own status. In 2022 FDA responded to new dietary ingredient notifications for nicotinamide mononucleotide by concluding that NMN is excluded from the dietary supplement definition, on the basis that it had been authorized for investigation as a new drug. Nicotinamide riboside, by contrast, has cleared the notification route. These are distinct compounds with distinct regulatory histories and none of it changes what research-grade material is.
Status verified August 26, 2026.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
Compound identifiers, salt form and current certificate for the material we stock are on the NAD+ product record.
Bottom line
NAD+ fails in base, and water is what lets it fail. Keep the powder sealed, cold and dry, and warm the vial before opening it. Read the salt form, water content and assay off the certificate before trusting a vial mass.
What is NAD+ studied for?
Published research on NAD+ investigates the areas below, which is a different question from what NAD+ will do for anyone, a claim about a living system that nothing on this site is sold for.
What it is. Nicotinamide adenine dinucleotide, a helper molecule rather than a peptide.
What the research looks at. A very large basic-science record on how cells make energy, on oxidation and reduction, and on enzymes. Most of it is about what the molecule does inside cells rather than about any product sold in a vial.
How it is thought to work. It carries hydrogen back and forth in the reactions that make energy, switching between two forms, and it is also used up as raw material by two families of enzymes, the sirtuins and the PARPs. Its basic biochemistry is textbook material and nobody disputes it.
What is not established. Well-understood biochemistry says nothing about any particular preparation in a vial. NAD+ is chemically different from the precursors it is often lumped in with, and material of this kind pulls in water from the air and degrades in light, which makes the handling paperwork matter more than usual.
The full record, including the certificate for the lot in stock, is on the NAD+ product page.
Common questions
Does lyophilized NAD+ need to be frozen?
Why is pH more important than temperature for NAD+?
What should an NAD+ certificate report?
Why let a cold NAD+ vial warm before opening?
Published certificates for NAD+
Every figure below is read from a report the laboratory issued for that lot; each page carries the PDF and the lab's own verification link.
More handling guides
Sources
- Lowry, Passonneau and Rock, Journal of Biological Chemistry, 1961. Measured the stability of the oxidised and reduced pyridine nucleotides in acid and base; establishes the opposing acid-base lability that governs NAD+ solution handling.
- PubChem compound record for NAD+, NIH National Library of Medicine. Source for molecular formula, formula weight, CAS number and salt-form identifiers cited in this article.
- ICH Q1A(R2), Stability Testing of New Drug Substances and Products. Framework for why a stated shelf life requires a study on that material in that container; supports treating unstudied storage windows as unestablished.
- USP General Chapter <621>, Chromatography. System suitability and method performance expectations for the reversed-phase purity assay described here.
